Lan Song
110 Xiangya Road
Changsha, 410078, China
Changsha, 410078, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Junren Bufei Yixin Granules ameliorates hypoxic pulmonary hypertension by regulating RELM-β/SLC7A11/GPX4 signaling pathway
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: July 02, 2026
Junren Bufei Yixin Granules attenuates hypoxic pulmonary hypertension via PTBP1/PKM2 signaling pathway
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: March 12, 2026
Integrative Machine Learning and Experimental Validation Identify FIS1 as a Candidate Biomarker Linked to Mitochondrial Dynamics in Pulmonary Hypertension.
Journal: Cells
Published: December 22, 2025
Roles of Lipid Metabolism in Pulmonary Hypertension: Friend or Foe?
Journal: Biomolecules
Published: October 07, 2025
Lactate and Lactylation in Pulmonary Hypertension: Comprehensive Landscape and Future Perspectives.
Journal: International journal of medical sciences
Published: September 17, 2025
Metabolic Reprogramming Intermediates of Glucose Regulate Macrophage Polarization: An Important Direction for Ameliorating Pulmonary Vascular Remodeling.
Journal: Journal of inflammation research
Published: May 21, 2025
Sanguinarine Suppresses Lung Adenocarcinoma via TGF-β1/Smad3 Pathway: Insights from Network Analysis and Experimental Validation.
Journal: Current pharmaceutical design
Published: May 15, 2025
Phosphofructokinase-1 redefined: a metabolic hub orchestrating cancer hallmarks through multi-dimensional control networks.
Journal: Journal of translational medicine
Published: May 13, 2025
Rewriting the vascular script: epigenetic modifiers as scribes of metabolic reprogramming in pulmonary hypertension.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: April 26, 2025
Astragaloside IV alleviates hypoxic pulmonary hypertension by inhibiting RELM-β to reduce PINK1/Parkin-mediated mitophagy in pulmonary artery smooth muscle cells (PASMCs).
Journal: British journal of pharmacology
Published: December 12, 2024
Unlocking the gut-lung axis: Feixin decoction as a novel modulator in hypoxic pulmonary hypertension.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 30, 2024
Targeting necroptosis: a promising avenue for respiratory disease treatment.
Journal: Cell communication and signaling : CCS
Published: June 20, 2024
Last Updated: 09/26/2026